Veratridine-treated brain slices: A cellular model for epileptiform activity

Brain Research

Volumn 789, Issue 1, 1998, Pages 150-156

  Otoom, Sameer ^a   Tian, Lian Ming ^a   A Alkadhi, Karim ^a  

^a UNIVERSITY OF HOUSTON   (United States)

Author keywords

Anticonvulsants; Epilepsy; Hippocampus; Phenobarbital; Spontaneous bursting; Valproic acid; Veratridine

Indexed keywords

VERATRIDINE;

ANIMAL TISSUE; ANTICONVULSANT THERAPY; ARTICLE; BRAIN ELECTROPHYSIOLOGY; DRUG EFFECT; EPILEPSY; HIPPOCAMPUS; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ACTION POTENTIALS; ANIMALS; ANTICONVULSANTS; BRAIN; ELECTROPHYSIOLOGY; EPILEPSY; MALE; PHENOBARBITAL; RATS; RATS, SPRAGUE-DAWLEY; SYNAPTIC TRANSMISSION; VALPROIC ACID; VERATRIDINE;

EID: 0032489951     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(98)00026-2     Document Type: Article

References (37)

1. B.E. Alger, S.S. Dhanjal, R. Dinglidine, J. Garthwaite, G. Henderson, G.L. King, P. Lipton, A. North, P.A. Schwartzkroin, T.A. Sears, S.S. Tim, J. Williams, Brain slice methods, in: R. Dingledine (Ed.), Brain Slices, Plenum, New York, 1984, pp. 381-437.
2. Alkadhi K.A., Tian L.M. Veratridine-enhanced persistent sodium current induces bursting in CA1 pyramidal neurons. Neuroscience. 71:1996;625-632.
3. Armstrong C.M., Cota G. Calcium ion as a cofactor in Na channel gating. Proc. Natl. Acad. Sci. USA. 88:1991;6528-6531.
4. Bensimon G., Lacomblez L., Meininger V. A controlled trial of riluzole in amyotrophic lateral sclerosis. New Engl. J. Med. 330:1994;585-591.
5. Boxer P.A. Comparison of phenytoin with noncompetitive N-methyl-D-aspartate antagonists in a model of focal brain ischaemia in rat. Stroke. 21:1990;S47-S51. (Suppl).
6. Catterall W.A. Neurotoxins that act on voltage-sensitive sodium channels. Annu. Rev. Pharmacol. Toxicol. 20:1980;15-43.
7. Courtney K.R., Etter E.F. Modulated anticonvulsant block of sodium channels in nerve and muscles. Eur. J. Pharmacol. 88:1983;1-9.
8. De Deyn P.P., Macdonald R.L. Effects of antiepileptic drugs on GABA responses and on reduction of GABA responses by PTZ and DMCM on mouse neurons in cell culture. Epilepsia. 30:1989;17-25.
9. Faingold C.L., Browning R.A. Mechanisms of anticonvulsant drug action: II. Drugs primarily used for absence epilepsy. Eur. J. Pediatr. 146:1987;8-14.
10. + channels activated by veratridine and batrachotoxin. J. Gen. Physiol. 89:1987;459-480.
11. J.A. Garber, Diabetes mellitus, in: G.H. Stein (Ed.), Harrison's Principles of Internal Medicine, 4th edn., 1994, pp. 1391-1434.
12. Giroud M., Dumas R. Treatment of status epilepticus by sodium valproate. Neurophysiol. Clin. 18:1988;21-32.
13. Heinemann U., Franseschetti S., Hamon B., Konnerth A., Yaari Y. Effects of anticonvulsants on spontaneous epileptiform activity which develops in the absence of chemical synaptic transmission in hippocampal slices. Brain Res. 325:1985;349-352.
14. Heinemann U., Lux H.D., Gutnick M.J. Extracellular free calcium and potassium during paroxysmal activity in the cerebral cortex of the cat. Exp. Brain Res. 27:1977;237-243.
15. B. Hille, Modifiers of gating, in: Ionic Channels of Excitable Membranes, 2nd edn., Sunderland, MA, 1992, pp. 445-470.
16. Holsheimer J., Silva F.H.L. Propagation velocity of epileptiform activity in the hippocampus. Exp. Brain Res. 77:1989;69-78.
17. T.H. Huxley, Ion-conducting channels, sodium and potassium, in: W.G. Nayler (Ed.), Calcium Antagonists, Academic Press, New York, 1988, pp. 5-21.
18. Jefferys J.G.R., Haas H.L. Synchronized bursting of CA1 hippocampal pyramidal cells in the absence of synaptic transmission. Nature. 300:1982;448-450.
19. Lothman E.W., Bertram E.H., Stringer J.L. Functional anatomy of hippocampal seizures. Prog. Neurobiol. 37:1991;1-82.
20. R.L. Macdonald, Anticonvulsant and convulsant drug actions on vertebrate neurons in primary dissociated cell culture, in: P.A. Schwartzkroin, H.V. Wheal (Eds.), Electrophysiology of Epilepsy, Academic Press, 1984, pp. 353-387.
21. Macdonald R.L., Kelly K.M. Antiepileptic drug mechanisms of action. Epilepsia. 36:1995;S2-S12. Suppl 2.
22. Macdonald R.L., Kelly K.M. Mechanism of action of currently prescribed and newly developed antiepileptic drugs. Epilepsia. 35:1994;S41-S50. Suppl.
23. Mattson R.H. Selection of drugs for the treatment of epilepsy. Semin. Neurol. 10:1990;406-413.
24. McLean M.J., Macdonald R.L. Sodium valproate, but not ethosuximide, produces use- and voltage-dependent limitation of high frequency repetitive firing of action potentials of mouse central neurons in cell culture. J. Pharmacol. Exp. Ther. 237:1986;1001-1011.
25. Mousnier R.B., Couraud F. Role of voltage-dependent ion channels in epileptogenesis. Neurophys. Clin. 25:1993;395-421.
26. Ohta M., Narahashi Y., Keeler R.F. Effects of Veratrum alkaloids on membrane potential and conductance in squid and crayfish giant axons. J. Pharmacol. Exp. Ther. 184:1973;143-154.
27. Okiyama K., Smith D.H., Gennarelli T.A., Simon R.P., Leach M., McIntosh T.K. The sodium channel blocker and glutamate release inhibitor BW1003C87 and magnesium attenuate regional cerebral edema following experimental brain injury in the rat. J. Neurochem. 64:1995;802-809.
28. D.A. Prince, Epileptogenesis in hippocampal and neocortical neurons, in: M.R. Klee (Ed.), Physiology and Pharmacology of Epileptogenic Phenomena, 1982, pp. 151-161.
29. Rando T.A. Rapid and slow gating of veratridine-modified sodium channels in frog myelinated nerve. J. Gen. Physiol. 93:1989;43-65.
30. Lifarizine study group, Squire I.B., Lees K.R., Pryse-phillips W., Kertesz A., Bamford J. Efficacy and tolerability of lifarizine in acute ischemic stroke. A pilot study. Ann. NY Acad. Sci. 765:1995;317-318.
31. Taylor C.P., Dudek F.E. Excitation of hippocampal pyramidal cells by an electrical field effect. J. Neurophysiol. 52:1984;126-142.
32. Tian L.M., Otoom S., Alkadhi K.A. Endogenous bursting due to altered sodium function in rat hippocampal CA1 neurons. Brain Res. 680:1995;164-172.
33. Twyman R.E., Rogers C.J., Macdonald R.L. Differential regulation of gamma-aminobutyric acid receptor channels by diazepam and phenobarbital. Ann. Neurol. 25:1989;213-220.
34. Wilbur R., Kulik F.A. Anticonvulsant drugs in alcohol withdrawal: use of phenytoin, primidone, carbamazepine, valproic acid, and the sedative anticonvulsants. Am. J. Hosp. Pharm. 38:1981;1138-1143.
35. Willow M., Kuenzel E.A., Catterall W.A. Inhibition of voltage-sensitive sodium channels in neuroblastoma cells and synaptosomes by the anticonvulsant drugs diphenylhydantoin and carbamazepine. Mol. Pharmacol. 25:1984;228-234.
36. Yaari Y., Konnerth A., Heinemann U. Spontaneous epileptiform activity of CA1 hippocampal neurons in low extracellular calcium solutions. Exp. Brain Res. 51:1983;153-156.
37. Y. Yaari, Nonsynaptic mechanisms and interictal-ictal transitions in the mammalian hippocampus. In: M.A. Dichter (Ed.), Mechanisms of Epileptogenesis, The Transition to Seizure, Plenum, 1986, pp. 183-198.